Aaron Ritter is a Psychiatry physician. OpenAlex indexes 137 publications with 4,796 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
888 W Bonneville Ave
Las Vegas, NV 891060100
Telephone
702-701-7981Registry record last updated 7 Jul 2016.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202528 payments$60,886openpaymentsdata.cms.gov ↗
- Otsuka America Pharmaceutical, Inc.Program year20258 payments$10,007openpaymentsdata.cms.gov ↗
- ACADIA Pharmaceuticals IncProgram year202517 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.9%Cholinesterase Inhibitor35.9%Donepezil Hcl63%Galantamine Er22%Rivastigmine11%Adlarity4%Galantamine Hbr1%Part D<11 patientsSSRI17.1%Escitalopram Oxalate62%Trazodone Hcl22%Sertraline Hcl7%Fluoxetine Hcl5%Citalopram Hbr4%Part D<11 patients+ 14 more classes in this area
Respiratory
0.6%beta2-Adrenergic Agonist0.3%Albuterol Sulfate Hfa100%Part D<11 patientsCorticosteroid0.3%Fluticasone Propionate100%Part D<11 patientsGenitourinary & hormones
0.5%beta3-Adrenergic Agonist0.5%Myrbetriq100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Building Trustworthy Generative Artificial Intelligence for Diabetes Care and Limb Preservation: A Medical Knowledge Extraction Case
Journal of Diabetes Science and Technology
2024 - Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
Alzheimer s & Dementia Translational Research & Clinical Interventions
2024 - Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment
Proceedings of the National Academy of Sciences
2023
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”